Biohaven Ltd. (BHVN) Price & Analysis

Compare

646 Followers

BHVN Stock Chart & Stats

Day’s Range― - ―

52-Week Range$12.79 - $55.70

Previous CloseN/A

Volume146.24K

Average Volume (3M)1.85M

Market Cap

$1.56B

Enterprise Value$2.16B

Total Cash (Recent Filing)$322.75M

Total Debt (Recent Filing)$35.51M

Price to Earnings (P/E)―

Beta1.46

Next Earnings

Aug 04, 2025

EPS Estimate

-1.9

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.17

Shares Outstanding102,112,526

10 Day Avg. Volume2,286,623

30 Day Avg. Volume1,854,520

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap1.39

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-2.21K

Enterprise Value/Ebitda-2.36

Forecast

1Y Price Target

$51.43

Price Target Upside249.63% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering9

Bulls Say, Bears Say

Bulls Say

Pipeline ExpansionBiohaven's pipeline is considered one of the most expansive in smidcap biotech, attracting significant investor interest.

Regulatory ApprovalTroriluzole would represent the first FDA-approved therapy for the treatment of SCA, highlighting its potential significance in the market.

Research And DevelopmentThe involvement of top scientists and physicians in Biohaven's R&D review day highlights the credibility and expertise backing its research programs.

Bears Say

Investor SkepticismNew data to address areas of investor skepticism showed very low incidence of CNS-AEs, which may serve as a point of competitive differentiation.

Regulatory DelaysThe FDA recently extended the PDUFA date for the NDA of troriluzole in SCA by 3 months, indicating potential regulatory delays.

Biohaven Ltd. News

Biotech stocks rise following Prasad exit from FDA

Shares of several biotech names are on the rise on Wednesday after Vinay Prasad, a top regulator at...

9d ago

BHVN

CAPR

BHVN Earnings this Week: How Will it Perform?

Biohaven Ltd. (BHVN) is scheduled to report 2nd quarter earnings on 08/04/2025. Regarding Q2 estimates, Wall Street analysts...

6d ago

BHVN

Biohaven Faces Investor Fury Over Misleading Claims

In a dramatic turn of events, Biohaven Ltd. finds itself at the center of a class action lawsuit,...

22d ago

BHVN

FDA flags possible safety signals in new report, says RBC Capital

RBC Capital notes that the FDA has, for the first time, published a report highlighting potential safety signals...

1M ago

ALKS

ARGX

3 Best Stocks to Buy Now, 6/19/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below...

2M ago

BHVN

BLZE

Biohaven price target lowered to $55 from $68 at JPMorgan

JPMorgan analyst Tessa Romero lowered the firm’s price target on Biohaven (BHVN) to $55 from $68 and keeps...

2M ago

BHVN

Bexorg announces multi-program research collaboration with Biohaven

Bexorg, which describes itself as “a pioneering techbio company working to decode the human brain and advance new...

2M ago

BHVN

Biohaven Ltd. Highlights Strategic Focus in Investor Presentation

The latest update is out from Biohaven Ltd. ( ($BHVN) ). On June 4, 2025, Biohaven Ltd. will...

2M ago

BHVN

3 Best Stocks to Buy Now, 6/2/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below...

2M ago

BHVN

DKNG

3 Best Stocks to Buy Now, 5/30/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below...

2M ago

BHVN

DKNG

Biohaven Ltd. Receives Buy Rating from Douglas Tsao Amid Promising R&D Advancements and Strategic Developments

H.C. Wainwright analyst Douglas Tsao has reiterated their bullish stance on BHVN stock, giving a Buy rating yesterday....

2M ago

BHVN

Biohaven Ltd. Receives Buy Rating Amidst Promising Developments and Strategic Advancements

Leerink Partners analyst Marc Goodman has maintained their bullish stance on BHVN stock, giving a Buy rating yesterday....

2M ago

BHVN

Biohaven initiates global Phase 2/3 study of BHV-8000

Biohaven (BHVN) announced that it has initiated a global Phase 2/3 study of the first-in-clinic, orally-administered, brain-penetrant, and...

2M ago

BHVN

Optimistic Buy Rating for Biohaven Ltd. Amid Promising Pipeline and Regulatory Challenges

William Blair analyst Myles Minter has reiterated their bullish stance on BHVN stock, giving a Buy rating yesterday....

2M ago

BHVN

BHVN FAQ

What was Biohaven Ltd.’s price range in the past 12 months?

Biohaven Ltd. lowest stock price was $12.79 and its highest was $55.70 in the past 12 months.

What is Biohaven Ltd.’s market cap?

Biohaven Ltd.’s market cap is $1.56B.

When is Biohaven Ltd.’s upcoming earnings report date?

Biohaven Ltd.’s upcoming earnings report date is Aug 04, 2025 which is 4 days ago.

How were Biohaven Ltd.’s earnings last quarter?

Currently, no data Available

Is Biohaven Ltd. overvalued?

According to Wall Street analysts Biohaven Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Biohaven Ltd. pay dividends?

Biohaven Ltd. does not currently pay dividends.

What is Biohaven Ltd.’s EPS estimate?

Biohaven Ltd.’s EPS estimate is -1.9.

How many shares outstanding does Biohaven Ltd. have?

Biohaven Ltd. has 102,112,526 shares outstanding.

What happened to Biohaven Ltd.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Biohaven Ltd.?

Currently, no hedge funds are holding shares in BHVN

Biohaven Ltd. Stock Smart Score

Neutral

Fundamentals

Return on Equity

-316.82%

Trailing 12-Months

Asset Growth

9.66%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Biohaven Ltd.

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.

Biohaven Ltd. (BHVN) Earnings & Revenues

Currently, no data available

Please return soon. This page is being updated.

Historic Earnings Reports

BHVN Stock 12 Month Forecast

Average Price Target

$51.43

▲(249.63% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","28":"$28","44":"$44","60":"$60","76":"$76"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$75.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":51.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$51.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$21.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,28,44,60,76],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.96,18.655384615384616,23.35076923076923,28.046153846153846,32.74153846153846,37.43692307692308,42.13230769230769,46.82769230769231,51.52307692307692,56.21846153846153,60.91384615384615,65.60923076923078,70.30461538461537,{"y":75,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.96,16.842307692307692,19.724615384615383,22.606923076923078,25.48923076923077,28.37153846153846,31.253846153846155,34.136153846153846,37.01846153846154,39.90076923076923,42.78307692307692,45.66538461538461,48.54769230769231,{"y":51.43,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.96,14.501538461538463,15.043076923076924,15.584615384615386,16.126153846153848,16.66769230769231,17.20923076923077,17.75076923076923,18.292307692307695,18.833846153846153,19.37538461538462,19.916923076923077,20.45846153846154,{"y":21,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.31,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.13,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.4,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.57,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.88,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.74,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.35,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.25,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.18,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.6,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.45,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.96,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >